Sonoma Pharmaceuticals, Inc. (SNOA)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.33M |
| Enterprise Value | 307.63k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.08 |
| Price/Book (mrq) | 0.35 |
| Enterprise Value/Revenue | 0.02 |
| Enterprise Value/EBITDA | -0.07 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.29 |
| 52-Week Change 3 | -85.29% |
| S&P500 52-Week Change 3 | 25.38% |
| 52 Week High 3 | 1.5200 |
| 52 Week Low 3 | 0.1200 |
| 50-Day Moving Average 3 | 0.1534 |
| 200-Day Moving Average 3 | 0.4008 |
Share Statistics
| Avg Vol (3 month) 3 | 451.16k |
| Avg Vol (10 day) 3 | 131.63k |
| Shares Outstanding 5 | 15.61M |
| Implied Shares Outstanding 6 | 16.04M |
| Float 8 | 15.35M |
| % Held by Insiders 1 | 1.56% |
| % Held by Institutions 1 | 2.23% |
| Shares Short (Apr 15, 2024) 4 | 214.16k |
| Short Ratio (Apr 15, 2024) 4 | 0.26 |
| Short % of Float (Apr 15, 2024) 4 | 1.39% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.37% |
| Shares Short (prior month Mar 15, 2024) 4 | 117.8k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jun 20, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:9 |
| Last Split Date 3 | Jun 20, 2019 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Mar 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -41.23% |
| Operating Margin (ttm) | -26.90% |
Management Effectiveness
| Return on Assets (ttm) | -19.44% |
| Return on Equity (ttm) | -82.87% |
Income Statement
| Revenue (ttm) | 12.31M |
| Revenue Per Share (ttm) | 1.95 |
| Quarterly Revenue Growth (yoy) | 6.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | -4.27M |
| Net Income Avi to Common (ttm) | -5.08M |
| Diluted EPS (ttm) | -0.8200 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.41M |
| Total Cash Per Share (mrq) | 0.15 |
| Total Debt (mrq) | 385k |
| Total Debt/Equity (mrq) | 5.75% |
| Current Ratio (mrq) | 4.07 |
| Book Value Per Share (mrq) | 0.49 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4.99M |
| Levered Free Cash Flow (ttm) | -4.58M |
© 2024 Yahoo. All rights reserved.